-
1
-
-
9644272621
-
HIV dementia: An evolving disease
-
McArthur JC. HIV dementia: an evolving disease. J Neu-roimmunol 2004;157:3-10.
-
(2004)
J Neu-roimmunol
, vol.157
, pp. 3-10
-
-
McArthur, J.C.1
-
2
-
-
78650834306
-
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
-
Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010;75:2087-2096.
-
(2010)
Neurology
, vol.75
, pp. 2087-2096
-
-
Heaton, R.K.1
Clifford, D.B.2
Franklin Jr., D.R.3
-
3
-
-
0029295139
-
The HNRC 500- neuropsychology of HIV infection at different disease stages: HIV Neurobehavioral Research Center
-
Heaton RK, Grant I, Butters N, et al. The HNRC 500- neuropsychology of HIV infection at different disease stages: HIV Neurobehavioral Research Center. J Int Neu-ropsychol Soc 1995;1:231-251.
-
(1995)
J Int Neu-ropsychol Soc
, vol.1
, pp. 231-251
-
-
Heaton, R.K.1
Grant, I.2
Butters, N.3
-
4
-
-
35848953181
-
Updated research nosology for HIV-associated neurocognitive disorders
-
Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69:1789-1799.
-
(2007)
Neurology
, vol.69
, pp. 1789-1799
-
-
Antinori, A.1
Arendt, G.2
Becker, J.T.3
-
5
-
-
67349242972
-
Drug abuse and hepatitis C infection as comorbid features of HIV associated neu-rocognitive disorder: Neurocognitive and neuroimaging features
-
Martin-Thormeyer EM, Paul RH. Drug abuse and hepatitis C infection as comorbid features of HIV associated neu-rocognitive disorder: neurocognitive and neuroimaging features. Neuropsychol Rev 2009;19:215-231.
-
(2009)
Neuropsychol Rev
, vol.19
, pp. 215-231
-
-
Martin-Thormeyer, E.M.1
Paul, R.H.2
-
6
-
-
68249156652
-
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
-
Cysique LA, Vaida F, Letendre S, et al. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 2009;73:342-348.
-
(2009)
Neurology
, vol.73
, pp. 342-348
-
-
Cysique, L.A.1
Vaida, F.2
Letendre, S.3
-
7
-
-
77649304791
-
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era
-
Cohen RA, Harezlak J, Schifitto G, et al. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of neurovirology 2010;16:25-32.
-
(2010)
Journal of Neurovirology
, vol.16
, pp. 25-32
-
-
Cohen, R.A.1
Harezlak, J.2
Schifitto, G.3
-
8
-
-
67650334380
-
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals
-
Gongvatana A, Schweinsburg BC, Taylor MJ, et al. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol 2009;15:187-195.
-
(2009)
J Neurovirol
, vol.15
, pp. 187-195
-
-
Gongvatana, A.1
Schweinsburg, B.C.2
Taylor, M.J.3
-
9
-
-
51349138915
-
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among non-demented individuals infected with HIV
-
Paul RH, Ernst T, Brickman AM, et al. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among non-demented individuals infected with HIV. J Int Neuropsychol Soc 2008;14:725-733.
-
(2008)
J Int Neuropsychol Soc
, vol.14
, pp. 725-733
-
-
Paul, R.H.1
Ernst, T.2
Brickman, A.M.3
|